Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02769442 · ClinicalTrials.gov registry record · NA
Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED
A NA study, sponsored by University of Maryland, Baltimore.
- Completed
- Registry status
- NA
- Development phase
- 600
- Enrollment target
NCT02769442 is a NA study that has completed, run by University of Maryland, Baltimore. The registered enrollment target is 600 participants.
The verdict
NCT02769442, a NA study, has completed, sponsored by University of Maryland, Baltimore.
- COMPLETED
- Registry status
- NA
- Development phase
- 600 participants
- Enrollment target
Study Summary
A randomized prospective comparison of two FDA approved intravenous catheters in the emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise to increase intravenous access success rates and decrease blood contamination of the insertion site. This study would analyze these properties in our busy, urban emergency department setting where time and safety of intravenous access are most critical.
Interventions
- DEVICE Terumo SurFlash Plus catheter
- DEVICE BD Insyte Autoguard catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 600 participants |
| Start Date | 2016-06 |
| Est. Completion | 2016-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02769442
The ClinicalTrials.gov registry entry for NCT02769442 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 600 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Maryland, Baltimore, which has 560 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Terumo SurFlash Plus catheter is the first listed.
NCT02769442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02769442 about?
NCT02769442 is a clinical study titled "Prospective, Randomized Controlled Comparison of TERUMO SurFlash Plus Versus BD Insyte Autoguard in an Urban ED". A randomized prospective comparison of two FDA approved intravenous catheters in the emergency department setting. The Terumo SurFlash Plus offers novel technologies that promise to increase intravenous access success rates and decrease blood contamination of the insertion site. This study would ana...
What is the current status of trial NCT02769442?
This trial is currently completed. It is a NA study. The enrollment target is 600 participants. The study started on 2016-06. Estimated completion is 2016-10.
What interventions are being tested in trial NCT02769442?
The interventions under investigation include: Terumo SurFlash Plus catheter (DEVICE), BD Insyte Autoguard catheter (DEVICE).
Who is sponsoring clinical trial NCT02769442?
This trial is sponsored by University of Maryland, Baltimore, which has 560 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.